Introduction: CDK4/6 inhibitors are a class of drugs that target enzymes, called CDK4 and CDK6. ... These drugs are used in combination with hormone therapy to treat hormone receptor-positive, HER2-negative metastatic breast cancers. Abemaciclib may also be used alone to treat these cancers.